Quality of Life and Gut Health in Pediatric Patients With Cystic Fibrosis
Recruiting
N/A
Interventional Study
Cystic Fibrosis in Children
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 2 – 18
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 40 (estimated)
- Sponsor
- Oslo University Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The aim of the present study is to investigate the effect of probiotic supplementation on GI related quality of life, through a randomised placebo-controlled clinical trial. Moreover, the invetigators wish to study CF microbiota and intestinal inflammation in the setting of probiotic supplementation and newly started treatment with a highly effective CF-specific treatment, elexacaftor-tezacaftor-i…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion criteria for WP1:
* CFTR mutations eligible for treatment with ETI
* Age 2-18 years. Majority of patients will be 2-6 years of age as ETI was approved from 6 years of age in 2022, and will be available for children above 2 years from 2024.
* Included in the Norwegian CF Register and conse…
Contacts
No contact information available.